13F HOLDINGS REPORT
Stonepine Capital Management, LLC
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0000935836-25-000151
Total Value
$123.9M
Positions
52
Other Managers
0
Confidential Omitted
No
Holdings (52)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ADMA BIOLOGICS INC | ADMA | 1,241,032 | $21.3M | 17.18% |
| 2 | EVOLUS INC | EOLS | 1,264,651 | $14.0M | 11.27% |
| 3 | TELA BIO INC | TELA | 2,353,099 | $7.1M | 5.74% |
| 4 | GALAPAGOS NV-SPON ADR | GLPGF | 200,000 | $5.5M | 4.44% |
| 5 | ZEVRA THERAPEUTICS INC | ZVRA | 597,700 | $5.0M | 4.02% |
| 6 | VERASTEM INC | VSTM | 870,000 | $4.5M | 3.63% |
| 7 | ACADIA PHARMACEUTICALS INC | ACAD | 220,000 | $4.0M | 3.26% |
| 8 | OPTINOSE INC | 68404V209 | 588,657 | $3.9M | 3.17% |
| 9 | ANIKA THERAPEUTICS INC | ANIK | 238,222 | $3.9M | 3.17% |
| 10 | INDIVIOR PLC | INDV | 305,000 | $3.8M | 3.06% |
| 11 | ESTABLISHMENT LABS HOLDINGS | ESTA | 80,002 | $3.7M | 2.98% |
| 12 | INHIBIKASE THERAPEUTICS INC | IKT | 1,132,388 | $3.7M | 2.97% |
| 13 | UROGEN PHARMA LTD | URGN | 324,324 | $3.5M | 2.79% |
| 14 | XOMA CORP | XOMAP | 125,700 | $3.3M | 2.67% |
| 15 | DAY ONE BIOPHARMACEUTICALS I | DAWN | 235,000 | $3.0M | 2.40% |
| 16 | IRONWOOD PHARMACEUTICALS INC | IRWD | 648,785 | $2.9M | 2.32% |
| 17 | SCPHARMACEUTICALS INC | 810648105 | 683,530 | $2.4M | 1.95% |
| 18 | SURROZEN INC | SRZNW | 137,200 | $2.0M | 1.59% |
| 19 | INOVIO PHARMACEUTICALS INC | INO | 1,050,000 | $1.9M | 1.55% |
| 20 | ENANTA PHARMACEUTICALS INC | ENTA | 331,900 | $1.9M | 1.54% |
| 21 | MYOMO INC | MYO | 274,426 | $1.8M | 1.43% |
| 22 | CALCIMEDICA INC | CALC | 468,793 | $1.7M | 1.34% |
| 23 | ACLARIS THERAPEUTICS INC | ACRS | 663,405 | $1.6M | 1.33% |
| 24 | PROFOUND MEDICAL CORP | PROF | 200,000 | $1.5M | 1.21% |
| 25 | JAZZ PHARMACEUTICALS PLC US LISTED | JAZZ | 10,000 | $1.2M | 0.99% |
| 26 | VIR BIOTECHNOLOGY INC | VIR | 164,106 | $1.2M | 0.97% |
| 27 | MILESTONE PHARMACEUTICALS IN | MIST | 500,000 | $1.2M | 0.95% |
| 28 | ANI PHARMACEUTICALS INC | ANIP | 20,400 | $1.1M | 0.91% |
| 29 | HERON THERAPEUTICS INC | HRTX | 700,000 | $1.1M | 0.86% |
| 30 | EXAGEN INC | XGN | 251,049 | $1.0M | 0.83% |
| 31 | 2SEVENTY BIO INC | 901384107 | 300,000 | $882,000 | 0.71% |
| 32 | ITEOS THERAPEUTICS INC | 46565G104 | 110,000 | $844,800 | 0.68% |
| 33 | PMV PHARMACEUTICALS INC | PMVP | 535,805 | $809,066 | 0.65% |
| 34 | KEZAR LIFE SCIENCES INC | KZR | 110,000 | $739,200 | 0.60% |
| 35 | AYTU BIOPHARMA INC | AYTU | 407,549 | $692,833 | 0.56% |
| 36 | ADICET BIO INC | ACET | 700,000 | $673,400 | 0.54% |
| 37 | KIORA PHARMACEUTICALS INC | KPHMW | 200,970 | $663,201 | 0.54% |
| 38 | XERIS BIOPHARMA HOLDINGS INC | XERS | 182,317 | $618,055 | 0.50% |
| 39 | AQUESTIVE THERAPEUTICS INC | AQST | 160,000 | $569,600 | 0.46% |
| 40 | APREA THERAPEUTICS INC | APRE | 149,221 | $490,937 | 0.40% |
| 41 | ACELYRIN INC | 00445A100 | 132,870 | $417,212 | 0.34% |
| 42 | COHERUS BIOSCIENCES INC | CHRS | 250,000 | $345,000 | 0.28% |
| 43 | POLYPID LTD | PYPD | 103,668 | $315,151 | 0.25% |
| 44 | HILLEVAX INC | 43157M102 | 132,347 | $273,958 | 0.22% |
| 45 | AN2 THERAPEUTICS INC | ANTX | 196,732 | $271,490 | 0.22% |
| 46 | VANDA PHARMACEUTICALS INC | VNDA | 25,000 | $119,750 | 0.10% |
| 47 | ELEVATION ONCOLOGY INC | 28623U101 | 200,000 | $112,520 | 0.09% |
| 48 | ABIVAX SA | AAVXF | 15,000 | $109,800 | 0.09% |
| 49 | ALIMERA SCIENCES INC CVR | 016CVR029 | 2,408,469 | $107,124 | 0.09% |
| 50 | ALLARITY THERAPEUTICS INC | ALLR | 67,289 | $78,728 | 0.06% |
| 51 | REVANCE THERAPEUTICS INC | 761330109 | 23,264 | $70,723 | 0.06% |
| 52 | AMARIN CORPORATION PLC -ADR | AMRN | 114,257 | $55,415 | 0.04% |